An understanding of the balance between the therapeutic benefit of pharmaceuticals and their potential risk is essential. An estimated 2.8 billion prescriptions are filled annually in the U.S. Adverse drug events could occur in as many as 2 million of them.
Pharmacoepidemiology, the study of the use and effect of prescription drugs, is a focal area of research and training at SLUCOR. Our faculty
investigate the use and effectiveness of medications and develop analytic methods to detect and study adverse drug events. Our team also examines how patients comply with instructions for their prescriptions, as well as the many complex factors surrounding adverse drug events.
Research spotlight: SLUCOR investigators work with the FDA, the Observational Medical Outcomes Partnership, and the Veteran's Health Administration on research projects including the development of new signal detection methodologies, analysis to clarify suspected relationships between antidiabetic medications and adverse health outcomes, and strategies to translate those findings into changes that benefit the public. Read more about SLUCOR's research in the area of pharmacoepidemiology.
Director: Dr. Scott Devine and Dr. Thomas E. Burroughs